PLAQUENIL®
children 10 mg base/kg may be taken in two divided doses, six hours apart. The suppressive therapy should be continued for eight weeks after leaving the endemic area. Treatment of the acute attack— In adults, an initial dose of 800 mg (= 620 mg base) followed by 400 mg (=310 mg base) in six to eight hours and 400 mg (=310 mg base) on each of
Download PLAQUENIL®
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
Singulair (Montelukast Sodium)
www.accessdata.fda.govprolonged T max from 2.3 ... 4-mg oral granule formulation in pediatric patients 6 to 23 months of age, the 4-mg chewable tablets in pediatric patients 2 to 5 years of age, the 5-mg chewable tablets in pediatric patients 6 to 14 years of age,
HIGHLIGHTS OF PRESCRIBING INFORMATION • For …
packageinserts.bms.comThe dose is 10 mg per kg. – Calculated Dose: 64 kg × 10 mg per kg = 640 mg – The closest doses evenly divisible by 12.5 mg below and above 640 mg are 637.5 mg and 650 mg. – The nearest dose to 640 mg is 637.5 mg. – Therefore, the actual prescribed dose for the patient should be 637.5 mg.
PRODUCT MONOGRAPH GRAVOL
pdf.hres.caParental / 50 mg per 1 mL vial 50% propylene glycol, water for injection, hydrochloric acid and sodium hydroxide for pH adjustment GRAVOL Immediate Release & Long Acting Caplets Oral Caplets / 100 mg total dimenhydrinate: 25 mg dimenhydrinate for immediate release and 75 mg dimenhydrinate for sustained release.
Adult Quick IV Push ED Reference Table
www.med.unc.edu3 mg Administer IVP over 15 seconds . Administer IVP over 30 seconds . Stable in D5W, LR, NS Haldol [lactate solution] (haloperidol) 0.5-10mg Geriatric Max rate of 5mg/minute : Max 5mg/minute IVP over 1-2 minutes Stable in D5W variable stability in D5¼NS, LR, ½NS Do not administer the deconate IV IV administration associated with prolonged QT and
Package Leaflet: Information for the patient
www.medicines.org.ukCircadin 2 mg prolonged-release tablets are available as white to off -white round bi -convex shaped tablets. Each carton of tablets contains one blister strip of 7, 20 or 21 tablets , or alternatively in a carton containing two blister strips of 15 tablets each (30 tablet pack). Not all pack sizes may be marketed.
Package Le aflet: Information for the user PROSTAP SR DCS
www.medicines.org.uk3.75 mg Powder and Solvent for Prolonged -release Suspension for Injection in Pre - filled Syringe . leuprorelin acetate . Read all of this leaflet carefully before you are given this medicine because it contains important information for you . • Keep …
HIGHLIGHTS OF PRESCRIBING INFORMATION NOXAFIL. …
www.merck.comLoading dose: 300 mg (three 100 mg delayed-release tablets) twice a day on the first day. Maintenance dose: 300 mg (three 100 mg delayed-release tablets) once a day, starting on the second day. Duration of therapy is based on recovery from neutropenia or immunosuppression. (2.2, 2.3) Noxafil Oral Suspension: 200 mg (5 mL) three times a day.